Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
333.28
+0.77 (+0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
39
40
Next >
A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls Over 1%
February 07, 2022
Pre-open movers
Via
Benzinga
Earnings Scheduled For February 7, 2022
February 07, 2022
Companies Reporting Before The Bell • NAPCO Security (NASDAQ:NSSC) is expected to report quarterly earnings at $0.10 per share on revenue of $31.60 million.
Via
Benzinga
Price To Earnings Ratio Insights For Amgen
February 03, 2022
Via
Benzinga
Expert Ratings For Amgen
January 05, 2022
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the l...
Via
Benzinga
5 Stocks To Watch For February 7, 2022
February 07, 2022
Some of the stocks that may grab inve3stor focus today are: Wall Street expects Tyson Foods, Inc. (NYSE: TSN) to report quarterly earnings at $1.90 per share on revenue of $12.18 billion after the...
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
A Preview Of Amgen's Earnings
February 04, 2022
Amgen (NASDAQ:AMGN) is set to give its latest quarterly earnings report on Monday, 2022-02-07. Here's what investors need to know before the announcement. Analysts estimate that Amgen will likely...
Via
Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
February 03, 2022
Photo by Diana Polekhina on Unsplash
Via
Benzinga
Will Moderna Sidestep The Looming Sales Cliff After FDA Approves Covid Shot?
January 31, 2022
Currently, analysts expect Moderna sales to drop off after 2022.
Via
Investor's Business Daily
Dogs of the Dow Dominating
January 27, 2022
A little more than half of the Dogs are in the black year to date compared to only three (of twenty) non-dogs that are positive.
Via
Talk Markets
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
January 27, 2022
As investor appetite for high-growth stocks begins to decrease in the new year, dividend stocks will likely to gain traction in 2022.
Via
InvestorPlace
Is Amgen (AMGN) A Good Stock To Buy?
January 25, 2022
The pharmaceutical sector has a lot of big companies that pay a growing dividend, and AMGN is one of them.
Via
Talk Markets
CNBC's Final Trades: Marvell, Amgen, Viper Energy, JPMorgan And This Tech Major That Is 'Way Too Cheap'
January 25, 2022
On CNBC’s “Halftime Report Final T...
Via
Benzinga
A New Oral Therapy for Psoriasis Could Be Coming Soon
January 24, 2022
Photo by Towfiqu barbhuiya on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice...
Via
Benzinga
14 Stocks in the Healthcare Sector
January 21, 2022
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%.
Via
Talk Markets
Amgen's Lumakras Approved In Japan For Pretreated Lung Cancer Patients
January 20, 2022
Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) has been approved in Japan for KRAS G12C-mutated positive, unresectable, advanced and/or recurrent non-small...
Via
Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In...
Via
Benzinga
3 Pharma Stocks Yielding Over 3%
January 18, 2022
The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries.
Via
Talk Markets
Inflation 2022 – Week In Review
January 17, 2022
Arguably, the number one concern in 2022 for most investors, consumers, and businesses is inflation. Inflation is rising in the US and globally, and recent reports this week were not good.
Via
Talk Markets
Blue-Chip Bank Earnings, Retail Data Drag Dow Lower
January 14, 2022
Within the last hour of trading, the S&P 500 and Nasdaq managed to eke out slight gains. All three major indexes fell for the week.
Via
Talk Markets
How Is The Market Feeling About Amgen Inc?
January 13, 2022
Amgen Inc's (NASDAQ:AMGN) short percent of float has fallen 11.74% since last its last report. The company recently reported that it has 11.40 million shares sold short, which is...
Via
Benzinga
A Look Into Amgen's Price Over Earnings
January 11, 2022
Right now, Amgen Inc. (NASDAQ:AMGN) share price is at $229.33, after a 0.45% drop. Over the past month, the stock went up by 7.29%, but over the past year, it...
Via
Benzinga
Europe Approves Amgen's KRAS-Targeted Lung Cancer Therapy
January 10, 2022
The European Commission (EC) has granted conditional marketing authorization to Amgen Inc's (NASDAQ: AMGN) Lumykras (sotorasib), a KRASG12C inhibitor, for...
Via
Benzinga
2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again?
January 09, 2022
The 2022 year has started quietly for SPACs, with no deals announced in the first five trading days of the year. Although two new SPAC rumors have popped up since the market...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich
Via
InvestorPlace
Financial Stocks Could be Positioned to Kick Off the Q4 Earnings Season
January 04, 2022
The U.S. dollar was rising against the Japanese yen Tuesday morning as foreign investors take notice of the jump in United States Treasury yields. The Japanese yen is now trading...
Via
Benzinga
Dogs Of The Dow Performance Does Not Keep Pace In 2021
January 01, 2022
In this past year, the 'Dogs of the Dow' strategy did not keep pace with either the Dow Jones Index or the S&P 500 Index. The Dow Dogs generated a total return of 16.3% versus 20.8% for the DJIA and...
Via
Talk Markets
Dogs of Major Indices
December 30, 2021
As we approach the end of 2021, we take a look at the ten Dow stocks that would currently make up the Dogs of the Dow for 2022.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
Upgrades According to TD Securities, the prior rating for Canada Goose Holdings Inc (NYSE:
Via
Benzinga
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.